Wauwatosa, WI, June 23, 2014 - GE Healthcare, (NYSE: GE), announced today clearance from the Food and Drug Administration (FDA) for its new Vivid T8TM cardiovascular ultrasound device. The 129-pound, mobile system features innovative quantitative features, stress echo and TEE capabilities, delivering exceptional value to healthcare providers looking for an affordable echo system.
Chalfont St Giles -- 18 June 2014-- GE Healthcare today announced that the OmnyxTM Integrated Digital Pathology (IDP) solution with the new VL120 high volume scanner has acquired the CE Mark for primary diagnosis in the European Union under the 'In Vitro Diagnostic Devices Directive'. The OmnyxTM IDP solution has been developed by Omnyx LLC, a joint venture of GE Healthcare and University of Pittsburgh Medical Center (UPMC).
business unit
tags
Москва, 18 июня 2014 - На XVI Московском международном курсе по рентген-эндоваскулярной диагностике и лечению (TCT Russia 2014), центральном российском событии в области рентгенэндоваскулярной хирургии, компания GE Healthcare провела уникальный научный симпозиум. В мероприятии принял участие мировой эксперт в этой области профессор Питер МакКуллах (Peter A. McCullough), который поделился своим опытом применения контрастных препаратов при проведении рентгенэндоваскулярных вмешательств. Ведущие российские специалисты также представили свой взгляд на эту проблему.
business unit
tags
ST. LOUIS -- Nuclear medicine scanning will be enriched with the introduction of GE Healthcare's Discovery*^ NM/CT 670 Pro, announced today at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI 2014). The vision of quantitative accuracy in nuclear medicine is enabled by Q.Metrix^ and Q.AC^, GE Healthcare's newest software innovations in nuclear medicine.
business unit
tags
ST. LOUIS -- Today at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT system, enabling both outstanding image quality and intelligent quantitation, helping physicians deliver the best possible patient outcomes.
business unit
tags
Solution helps enable patients' access to collaborative and subspecialty pathology services
Mississauga, ON -- June 1, 2014 -- GE Healthcare today announced that the OmnyxTM Integrated Digital Pathology (IDP) solution with the new VL120 high volume scanner has obtained a Health Canada Class II Medical Device License for primary diagnostic use. The OmnyxTM IDP with VL4 scanner was licensed in 2013 and has been developed by Omnyx, LLC, a joint venture of GE Healthcare and UPMC.